Literature DB >> 29905152

Epileptic seizure semiology in different age groups.

Guadalupe Fernandez-Baca Vaca1, Carlos L Mayor2, Naira García Losarcos3, Jun T Park1, Hans O Lüders1.   

Abstract

Seizure semiology provides information about the eloquent cortex involved during a seizure and helps to generate a hypothesis regarding the localization of the epileptogenic zone (EZ), a prerequisite for surgical management of epilepsy. We aimed to study the seizure semiology among all different age groups to better characterize semiological changes that occur with age. We performed a retrospective review of video-EEG data in paediatric and adult patients admitted to the Epilepsy Monitoring Unit over a three-year period. Authors independently reviewed and classified the seizure semiology while blinded to clinical, EEG, and neuroimaging data. A total of 270 patients were included in the study. The most frequent EZ in patients who were one month to three years old was undetermined. Focal epilepsy became more frequent in patients older than 10 years. Among patients with focal epilepsy, a posterior quadrant EZ was most frequent in children younger than three years old, a temporal EZ between three and six years old, and a frontal EZ between six and 10 years old. The temporal lobe was the most frequent location for focal EZ in patients older than 18 years. Auras, automotor seizures, and generalized tonic-clonic seizures were extremely infrequent in patients younger than 10 years old. The youngest patient with auras was 5.7 years old. The youngest patient with automotor seizures was 3.7 years old. We identified only three patients with generalized tonic-clonic seizures who were younger than 10 years (aged six months, 6.6 years, and nine years, respectively). Patients younger than three years exhibited mostly generalized simple motor seizures and hypomotor seizures. Generalized epileptic spasms, generalized tonic seizures, and generalized clonic seizures were infrequent in patients older than 10 years. Seizure semiology and electroencephalographic changes most likely reflect the maturation of cortical functions.

Entities:  

Keywords:  automotor seizures; epileptic auras; generalized tonic seizures; generalized tonic-clonic seizures; seizure semiology

Mesh:

Year:  2018        PMID: 29905152     DOI: 10.1684/epd.2018.0970

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  5 in total

1.  Late-onset epilepsy and 25-year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Emily L Johnson; Gregory L Krauss; Keenan A Walker; Jason Brandt; Anna Kucharska-Newton; Thomas H Mosley; Sevil Yasar; Rebecca F Gottesman
Journal:  Epilepsia       Date:  2020-07-24       Impact factor: 5.864

2.  Intra- and Inter-Subject Perspectives on the Detection of Focal Onset Motor Seizures in Epilepsy Patients.

Authors:  Sebastian Böttcher; Elisa Bruno; Nino Epitashvili; Matthias Dümpelmann; Nicolas Zabler; Martin Glasstetter; Valentina Ticcinelli; Sarah Thorpe; Simon Lees; Kristof Van Laerhoven; Mark P Richardson; Andreas Schulze-Bonhage
Journal:  Sensors (Basel)       Date:  2022-04-26       Impact factor: 3.847

3.  Differences in Evolution of Epileptic Seizures and Topographical Distribution of Tissue Damage in Selected Limbic Structures Between Male and Female Rats Submitted to the Pilocarpine Model.

Authors:  Daniel Matovu; Esper A Cavalheiro
Journal:  Front Neurol       Date:  2022-04-05       Impact factor: 4.003

4.  Clinical features and surgical outcomes in young children with focal cortical dysplasia type II.

Authors:  Tian-Shuang Wang; Qing-Zhu Liu; Ming Liu; Qian Zhang; Ruo-Fan Wang; Chong-Wei Wu; Jie Zhang; Wen Wang; Tao-Yun Ji; Xiao-Yan Liu; Shuang Wang; Li-Xin Cai; Yu-Wu Jiang; Ye Wu
Journal:  CNS Neurosci Ther       Date:  2019-08-01       Impact factor: 5.243

5.  Epilepsy Due to Mild TBI in Children: An Experience at a Tertiary Referral Center.

Authors:  Jun T Park; Sarah J DeLozier; Harry T Chugani
Journal:  J Clin Med       Date:  2021-12-03       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.